FXI News Alert FTSE China 25 Index Fund Ishares (FXI) 41.51 12/04/2014

New Post Public Reply Private Reply Replies (0) Message Board

Dec 4, 2014 at 6:22 PM

FTSE China 25 Index Fund Ishares (FXI) 41.51 $FXI

European Central Bank Decides... To Wait!
John M. Mason - at Seeking Alpha - Thu Dec 04, 11:09AM CST

IEV: 44.68 (-0.18), FXE: 121.95 (+0.68), FXI: 41.51 (+1.21)

CASS Researcher Forecasts Major Bull Market For China In 2015
Matthew Cowie - at Seeking Alpha - Thu Dec 04, 7:42AM CST

ASHR: 34.79 (+2.58), FXI: 41.51 (+1.21)

More On The China Trade
Owen Williams, CFA - at Seeking Alpha - Thu Dec 04, 6:40AM CST

ASHR: 34.79 (+2.58), FXI: 41.51 (+1.21)

Shanghai soars the most in two years
Seeking Alpha - at Seeking Alpha - Thu Dec 04, 5:32AM CST

EWH: 21.21 (-0.04), PEK: 41.80 (+1.97), CNXT: 31.21 (+0.67), KBA: 43.63 (+1.77), YINN: 34.85 (+2.91), CHXF: 52.82 (+1.42), FXP: 44.37 (-2.81), SNP: 84.77 (+5.95), PGJ: 29.27 (-0.13), EWHS: 28.39 (unch), FCA: 23.33 (+0.44), YAO: 28.54 (+0.66), PTR: 109.56 (+6.38), ASHR: 34.79 (+2.58), FCHI: 51.42 (+1.38), GXC: 80.70 (+1.41), FXI: 41.51 (+1.21), ASHS: 37.55 (+0.96), XPP: 67.37 (+3.74), CHNA: 32.06 (+1.90), MCHI: 50.40 (+1.17), YANG: 12.33 (-1.19), CHIE: 13.75 (unch), FHK: 39.19 (-0.04), YXI: 28.70 (-1.07), CN: 33.93 (+1.19)

Elephant, Meet China
Ilargi - Seeking Alpha - Wed Dec 03, 10:02AM CST
Oh man, I wanted to keep this short, what I wanted to say looked so straight-forward. But then, in this convoluted world of pretense, is anything ever anymore? Please allow me to start off with something I wrote yesterday in Oil, Gold And Now...
XPP: 67.37 (+3.74), YANG: 12.33 (-1.19), FXP: 44.37 (-2.81), PGJ: 29.27 (-0.13), FCA: 23.33 (+0.44), CHXF: 52.82 (+1.42), YAO: 28.54 (+0.66), YINN: 34.85 (+2.91), YXI: 28.70 (-1.07), CN: 33.93 (+1.19), MCHI: 50.40 (+1.17), GXC: 80.70 (+1.41), FXI: 41.51 (+1.21)

Daily State Of The Markets: The Bears Are Making Their List And Checking It Twice...
David Moenning - Seeking Alpha - Wed Dec 03, 7:32AM CST
Stocks rallied back on Tuesday as the S&P 500 erased the majority of Monday's decline. The venerable Dow Jones Industrial Average went one better and managed to close at a fresh new all-time high. However, the rest of the major indices did not...
SPY: 207.66 (-0.23), QQQ: 105.37 (-0.05), DIA: 178.83 (-0.13), EZU: 38.43 (-0.20), IWM: 116.81 (-0.56), EWJ: 11.74 (-0.03), FXI: 41.51 (+1.21)

Eco Data - Non-Manufacturing PMI For November 2014 Edges Up To 53.9
China Stock Research - Seeking Alpha - Wed Dec 03, 1:57AM CST
China's National Bureau of Statistics released the November reading for non-manufacturing PMI ( source: Chinese ), which rose slightly to 53.9 vs. 53.8 in October. The reading may come as somewhat of a relief to the market after the manufacturing...
XPP: 67.37 (+3.74), YANG: 12.33 (-1.19), FXP: 44.37 (-2.81), PGJ: 29.27 (-0.13), FCA: 23.33 (+0.44), CHXF: 52.82 (+1.42), YAO: 28.54 (+0.66), YINN: 34.85 (+2.91), YXI: 28.70 (-1.07), CN: 33.93 (+1.19), MCHI: 50.40 (+1.17), GXC: 80.70 (+1.41), FXI: 41.51 (+1.21)

Monetary Policy Decouples As Financial Crisis Enters Its Final Act
Alpha Now at Thomson Reuters - at Seeking Alpha - Tue Dec 02, 7:54PM CST
By Phillip Lachowycz We may finally be entering the final act of the financial crisis. The monetary policy of the major central banks is decoupling. The Federal Reserve and the Bank of England are moving towards an interest rate increase, albeit...
NKY: 17.72 (-0.02), DXJ: 56.80 (+0.10), DXPS: 25.70 (-0.15), SPY: 207.66 (-0.23), FKU: 39.75 (+0.14), QQQ: 105.37 (-0.05), EWU: 19.05 (-0.14), DIA: 178.83 (-0.13), PGJ: 29.27 (-0.13), YINN: 34.85 (+2.91), EWJ: 11.74 (-0.03), GXC: 80.70 (+1.41), FXI: 41.51 (+1.21)

Performance Divergence Among Asian ETFs
Moby Waller - Seeking Alpha - Tue Dec 02, 10:49AM CST
One of the nice things about ETFs is the broad diversity they offer in terms of exposure to a vast variety of stock sectors within the US - but they also have exposure to a growing number of international countries (and in some cases, multiple...
NKY: 17.72 (-0.02), DXJ: 56.80 (+0.10), EWY: 56.92 (+0.58), THD: 83.34 (-0.20), EWM: 13.78 (-0.18), FXI: 41.51 (+1.21), EWJ: 11.74 (-0.03)

How Might A China Slowdown Affect The World?
Michael Pettis - Seeking Alpha - Tue Dec 02, 9:17AM CST
Two years ago it was hard to find analysts who expected average GDP growth over the rest of this decade to be less than 8%. The current consensus seems to have dropped to between 6% and 7% on average. I don’t think Beijing disagrees. After ...
SPY: 207.66 (-0.23), QQQ: 105.37 (-0.05), IEV: 44.68 (-0.18), DIA: 178.83 (-0.13), FCA: 23.33 (+0.44), IWM: 116.81 (-0.56), FXI: 41.51 (+1.21)

Strangers Passing In The Night
Smead Capital Management - Seeking Alpha - Tue Dec 02, 7:12AM CST
The economies of China and the United States appear to be headed in the opposite direction. China's economy is decelerating fast and the U.S. looks right on the cusp of having its economic growth accelerate, as evidenced by the revised quarterly GDP...
XPP: 67.37 (+3.74), BAC: 17.21 (-0.08), WFC: 54.50 (+0.11), CHXF: 52.82 (+1.42), YINN: 34.85 (+2.91), MCHI: 50.40 (+1.17), YANG: 12.33 (-1.19), SPY: 207.66 (-0.23), JPM: 61.38 (-0.16), QQQ: 105.37 (-0.05), FXP: 44.37 (-2.81), PGJ: 29.27 (-0.13), FCA: 23.33 (+0.44), YAO: 28.54 (+0.66), YXI: 28.70 (-1.07), BEN: 57.96 (-0.07), CN: 33.93 (+1.19), FXI: 41.51 (+1.21), GXC: 80.70 (+1.41)

It's a bull market; Shanghai soars 3.1%
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 6:24AM CST

EWH: 21.21 (-0.04), PEK: 41.80 (+1.97), CNXT: 31.21 (+0.67), KBA: 43.63 (+1.77), YINN: 34.85 (+2.91), CHXF: 52.82 (+1.42), FXP: 44.37 (-2.81), PGJ: 29.27 (-0.13), EWHS: 28.39 (unch), FCA: 23.33 (+0.44), YAO: 28.54 (+0.66), ASHR: 34.79 (+2.58), FCHI: 51.42 (+1.38), GXC: 80.70 (+1.41), FXI: 41.51 (+1.21), ASHS: 37.55 (+0.96), XPP: 67.37 (+3.74), TAO: 21.83 (-0.09), CHNA: 32.06 (+1.90), CHIX: 15.33 (+0.55), MCHI: 50.40 (+1.17), YANG: 12.33 (-1.19), FHK: 39.19 (-0.04), YXI: 28.70 (-1.07), CN: 33.93 (+1.19)

China And Japan Converge
Markit - Seeking Alpha - Tue Dec 02, 3:27AM CST
China's spreads have rallied and Japan's have lost ground, leading to a convergence of the two sovereigns. Back in the summer of 2013, there were two main themes that investors feared could trigger a change in the credit cycle. The first was the US...
XPP: 67.37 (+3.74), JPNL: 44.87 (-0.13), CHXF: 52.82 (+1.42), YINN: 34.85 (+2.91), MCHI: 50.40 (+1.17), EWJ: 11.74 (-0.03), EWV: 61.13 (+0.20), DXJ: 56.80 (+0.10), NKY: 17.72 (-0.02), YANG: 12.33 (-1.19), HEWJ: 28.57 (-0.07), ITF: 50.28 (-0.04), FXP: 44.37 (-2.81), DBJP: 41.98 (-0.05), PGJ: 29.27 (-0.13), JPP: 45.17 (+0.07), FCA: 23.33 (+0.44), EZJ: 83.29 (-0.34), YAO: 28.54 (+0.66), FJP: 46.36 (-0.07), YXI: 28.70 (-1.07), CN: 33.93 (+1.19), FXI: 41.51 (+1.21), GXC: 80.70 (+1.41)

iShares FTSE Set to Possibly Rebound After Yesterday's Selloff of 2.62%
Comtex SmarTrend(R) - Mon Dec 01, 3:55PM CST
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $39.34 to a high of $39.59. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $39.68 on volume of 21.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FXI: 41.51 (+1.21)

iShares FTSE Falls 2.62% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Dec 01, 3:54PM CST
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $39.34 to a high of $39.59. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $39.68 on volume of 21.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FXI: 41.51 (+1.21)

China Continues To Take Advantage Of Lower Oil Prices
Dean Popplewell - Seeking Alpha - Mon Dec 01, 2:39PM CST
By Alfonso Esparza China is emerging as the winner from OPEC’s battle with rival oil producers, as the world’s biggest energy consumer stockpiles crude. The nation’s efforts to boost reserves may increase its imports by as much...
OIL: 16.05 (-0.19), FXI: 41.51 (+1.21)

The Periodic Table Of Emerging Markets 2004 To 2013
David Hunkar - at Seeking Alpha - Mon Dec 01, 12:26PM CST
The U.S. equity market has performed well so this year with only one more month left to go. As of November end, the S&P 500 is up by 11.9% based on price returns and the Dow is up by 7.6%. Among the emerging markets, India is the top performer...
EWW: 61.96 (-0.52), EZA: 66.73 (-0.85), INDY: 31.84 (+0.09), RSX: 18.66 (-0.51), EWZ: 39.13 (-0.74), FXI: 41.51 (+1.21)

Eco Data - November 2014 PMI Weakens To 50.3
China Stock Research - Seeking Alpha - Mon Dec 01, 8:39AM CST
The official PMI for November dropped to 50.3, well under the consensus expectation of 50.6. November's reading was a nine-month low, matching the mini-stimulus inspiring reading from March 2014. China's economy is clearly slowing down, and...
XPP: 67.37 (+3.74), YANG: 12.33 (-1.19), FXP: 44.37 (-2.81), PGJ: 29.27 (-0.13), FCA: 23.33 (+0.44), CHXF: 52.82 (+1.42), YAO: 28.54 (+0.66), YINN: 34.85 (+2.91), YXI: 28.70 (-1.07), CN: 33.93 (+1.19), MCHI: 50.40 (+1.17), GXC: 80.70 (+1.41), FXI: 41.51 (+1.21)

What's Behind China's Interest Rate Cut?
Invesco US - Seeking Alpha - Mon Dec 01, 8:13AM CST
By Paul Chan Last Friday, the People's Bank of China announced an asymmetrical rate cut of 25 and 40 basis points for the benchmark deposit and lending rates, respectively, effective starting Nov. 22, 2014. 1 Specifically: The one-year...
FXCH: 80.75 (-0.05), CNY: 42.59 (-0.01), EWH: 21.21 (-0.04), CHLC: 26.09 (unch), FXI: 41.51 (+1.21)

China drafts policy on emergency use of Ebola diagnostic products
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 7:48AM CST

EWH: 21.21 (-0.04), PEK: 41.80 (+1.97), CNXT: 31.21 (+0.67), KBA: 43.63 (+1.77), CQQQ: 35.81 (-0.16), YINN: 34.85 (+2.91), CHXF: 52.82 (+1.42), FXP: 44.37 (-2.81), EWHS: 28.39 (unch), PGJ: 29.27 (-0.13), FCA: 23.33 (+0.44), YAO: 28.54 (+0.66), FCHI: 51.42 (+1.38), ASHR: 34.79 (+2.58), ASHS: 37.55 (+0.96), GXC: 80.70 (+1.41), FXI: 41.51 (+1.21), XPP: 67.37 (+3.74), KWEB: 34.71 (-0.31), TAO: 21.83 (-0.09), ECNS: 46.95 (+0.08), CHNA: 32.06 (+1.90), QQQC: 22.48 (-0.07), CHIX: 15.33 (+0.55), KFYP: 66.00 (-1.53), HAO: 27.01 (+0.13), MCHI: 50.40 (+1.17), CHIM: 15.23 (unch), YANG: 12.33 (-1.19), CHIQ: 13.25 (unch), CHIE: 13.75 (unch), FHK: 39.19 (-0.04), YXI: 28.70 (-1.07), CHII: 13.58 (+0.27), CN: 33.93 (+1.19)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....